0.826
price up icon1.80%   0.0146
 
loading
Cue Biopharma Inc stock is traded at $0.826, with a volume of 172.80K. It is up +1.80% in the last 24 hours and down -8.12% over the past month. Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.
See More
Previous Close:
$0.8114
Open:
$0.82
24h Volume:
172.80K
Relative Volume:
0.57
Market Cap:
$63.47M
Revenue:
$9.53M
Net Income/Loss:
$-44.61M
P/E Ratio:
-0.9077
EPS:
-0.91
Net Cash Flow:
$-38.32M
1W Performance:
+0.00%
1M Performance:
-8.12%
6M Performance:
-37.42%
1Y Performance:
+1.34%
1-Day Range:
Value
$0.788
$0.85
1-Week Range:
Value
$0.77
$0.85
52-Week Range:
Value
$0.45
$1.9891

Cue Biopharma Inc Stock (CUE) Company Profile

Name
Name
Cue Biopharma Inc
Name
Phone
617-949-2680
Name
Address
40 GUEST STREET, BOSTON, MA
Name
Employee
41
Name
Twitter
@cuebiopharma
Name
Next Earnings Date
2025-03-31
Name
Latest SEC Filings
Name
CUE's Discussions on Twitter

Compare CUE with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
CUE
Cue Biopharma Inc
0.826 62.92M 9.53M -44.61M -38.32M -0.91
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
395.12 99.96B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
589.48 60.83B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
454.38 59.89B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
660.00 40.47B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
313.67 37.96B 3.81B -644.79M -669.77M -6.24

Cue Biopharma Inc Stock (CUE) Upgrades & Downgrades

Date Action Analyst Rating Change
Mar-13-24 Initiated Jefferies Buy
Jun-26-23 Resumed Oppenheimer Outperform
Nov-21-22 Initiated Piper Sandler Overweight
Jan-13-22 Initiated H.C. Wainwright Buy
Jan-03-22 Initiated Craig Hallum Buy
Nov-24-20 Initiated Berenberg Buy
Apr-09-20 Initiated Stifel Buy
Jan-28-20 Initiated BTIG Research Buy
Jan-22-20 Initiated JMP Securities Mkt Outperform
View All

Cue Biopharma Inc Stock (CUE) Latest News

pulisher
Aug 20, 2025

Has Cue Biopharma Inc. found a price floorMarket Trend Summary & Accurate Trade Setup Notifications - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Is Cue Biopharma Inc. stock entering bullish territory2025 Key Highlights & High Return Stock Watch Alerts - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Is Cue Biopharma Inc. forming a bottoming baseJuly 2025 Institutional & Long-Term Investment Growth Plans - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

When is the best time to exit Cue Biopharma Inc.July 2025 Update & Fast Gain Stock Trading Tips - Newser

Aug 20, 2025
pulisher
Aug 19, 2025

Predicting Cue Biopharma Inc. trend using moving averagesTrade Analysis Report & Growth Oriented Trade Recommendations - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Why Cue Biopharma Inc. stock is on top investor watchlists2025 Market Outlook & Daily Entry Point Alerts - beatles.ru

Aug 19, 2025
pulisher
Aug 19, 2025

Cue Biopharma Inc. stock trend forecast2025 Short Interest & Intraday High Probability Setup Alerts - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Evaluating Cue Biopharma Inc. with trendline analysisWeekly Trade Recap & Verified Momentum Watchlists - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Cue Biopharma Inc. stock daily chart insightsTrend Reversal & AI Forecast Swing Trade Picks - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Cue Biopharma’s Q2 2025: Strategic Advances and Financial Highlights - TipRanks

Aug 19, 2025
pulisher
Aug 18, 2025

Regression analysis insights on Cue Biopharma Inc. performanceLong Setup & Real-Time Buy Signal Notifications - Newser

Aug 18, 2025
pulisher
Aug 17, 2025

Published on: 2025-08-17 18:02:43 - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Intraday pattern recognizer results for Cue Biopharma Inc.Oil Prices & Verified Technical Signals - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Is Cue Biopharma Inc. trading at a discount2025 Support & Resistance & Target Return Focused Stock Picks - thegnnews.com

Aug 17, 2025
pulisher
Aug 17, 2025

Why Cue Biopharma Inc. stock attracts strong analyst attention2025 Macro Impact & Low Drawdown Momentum Ideas - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

How to read the order book for Cue Biopharma Inc.Risk Management & Real-Time Buy Signal Alerts - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

What makes Cue Biopharma Inc. stock price move sharplyIPO Watch & Free Fast Entry Momentum Trade Alerts - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

How to recover losses in Cue Biopharma Inc. stockShare Buyback & Daily Oversold Bounce Ideas - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Will Cue Biopharma Inc. stock go up soon2025 Historical Comparison & Weekly Top Gainers Trade List - Newser

Aug 17, 2025
pulisher
Aug 16, 2025

News impact scoring models applied to Cue Biopharma Inc.July 2025 Intraday Action & Daily Stock Trend Reports - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Should you avoid Cue Biopharma Inc. stock right nowFed Meeting & Low Risk High Reward Trade Ideas - thegnnews.com

Aug 16, 2025
pulisher
Aug 16, 2025

Using AI based signals to follow Cue Biopharma Inc.Take Profit & Real-Time Chart Breakout Alerts - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

How sentiment analysis helps forecast Cue Biopharma Inc.Market Activity Report & Daily Profit Maximizing Trade Tips - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Will Cue Biopharma Inc. stock benefit from interest rate changesJuly 2025 Outlook & Stepwise Entry/Exit Trade Alerts - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Published on: 2025-08-16 02:15:50 - Newser

Aug 16, 2025
pulisher
Aug 15, 2025

Order flow analysis tools used on Cue Biopharma Inc.2025 Market Outlook & Verified Short-Term Trading Plans - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Intrinsic Value of Cue Biopharma Inc. Stock: Is It Undervalued or OvervaluedWeekly Profit Report & Low Drawdown Investment Ideas - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

How Cue Biopharma Inc. stock performs during market volatilityDip Buying & Stepwise Trade Execution Plans - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Cue Biopharma Inc. Building a Base Near SupportStop Loss & Entry Point Strategy Guides - sundaytimes.kr

Aug 15, 2025
pulisher
Aug 15, 2025

What technical models suggest about Cue Biopharma Inc.’s comeback - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Cue Biopharma Reports Q2 2025 Earnings: Collaboration Revenue Exceeds Estimate, Net Loss Narrows - AInvest

Aug 15, 2025
pulisher
Aug 14, 2025

Cue Biopharma's Q2 2025 Earnings Beat and Revenue Growth: A Glimpse of Sustainable Turnaround Potential? - AInvest

Aug 14, 2025

Cue Biopharma Inc Stock (CUE) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$24.65
price up icon 0.94%
$85.04
price down icon 1.72%
$26.20
price up icon 0.73%
$110.88
price up icon 0.10%
$131.88
price down icon 0.54%
biotechnology ONC
$313.67
price down icon 0.10%
Cap:     |  Volume (24h):